结构化转归评分指导复杂结肠息肉内镜腹腔镜联合手术中的肿瘤性结肠切除术
溃疡或凹陷、病灶≥40mm及非抬举征与转 OC 独立相关,10分 CELS-OC 评分对转 OC 和恶性病理判别力强,高风险病灶(≥7分)转 OC 率和恶性率分别达93.8%和75.0%。
要点
- 溃疡或凹陷、病灶≥40mm、非抬举征是转 OC 的独立预测因素。
- CELS-OC 评分对转 OC 的 AUC 为0.928,对恶性的 AUC 为0.874。
- 高风险(≥7分)病灶转 OC 率93.8%、恶性率75.0%。
核心结论
- 复杂结肠息肉术前活检良性者中,特定形态学和术中特征与转 OC 及恶性病理相关。
- CELS-OC 评分将这些预测因素整合为结构化术中框架,可能改善保留器官的选择并维持肿瘤安全性。
- 需要外部验证。
研究设计与样本
- 主要终点为转 OC,次要终点包括病理恶性和≥T2病变。
- 采用 Firth 惩罚逻辑回归分析临床相关术前和术中变量,并用 bootstrap 重抽样进行内部验证。
- 衍生出10分 CELS-OC 评分并整合入逐步手术算法。
主要发现
- 溃疡或凹陷(aOR 19.15,95%CI 3.45-106.36;p<0.001)、病灶大小≥40mm(aOR 6.40,95%CI 1.35-30.33;p=0.019)和非抬举征(aOR 5.36,95%CI 1.05-27.44;p=0.044)与转 OC 独立相关。
- 溃疡或凹陷仍可预测恶性(aOR 13.07,95%CI 3.10-55.04;p=0.001)。
- 评分对转 OC 的判别力强(AUC 0.928),对恶性的判别力强(AUC 0.874)。
- 高风险病灶(≥7分)的转 OC 率和恶性率分别为93.8%和75.0%。
关键数值与推荐
- CELS-OC 评分为10分制,高风险定义为≥7分。
- 转 OC 的独立预测因素包括溃疡或凹陷、病灶≥40mm、非抬举征。
- 恶性预测因素为溃疡或凹陷。
临床怎么用
- 对于术前活检良性的复杂结肠息肉,术中可依据溃疡或凹陷、病灶≥40mm、非抬举征等特征评估转 OC 风险。
- CELS-OC 评分可辅助术中决策,高风险(≥7分)病灶转 OC 率和恶性率高,应考虑升级手术。
- 该评分尚需外部验证后方可广泛推广。
局限性
- 仅进行内部验证(bootstrap 重抽样),需要外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of complex colonic polyps with benign preoperative biopsy findings remains challenging when endoscopic resection is technically difficult or oncologic risk is uncertain. Combined endoscopic-laparoscopic surgery (CELS) offers an organ-preserving alternative to oncologic colectomy (OC), yet clear criteria for intraoperative decision-making are lacking. This study aimed to identify predictors of conversion from CELS to OC and malignant pathology and to develop an intraoperative risk score to guide escalation. METHODS: A single-center retrospective cohort study included consecutive patients treated between 2014 and 2024 for complex colonic polyps with benign preoperative biopsy findings using an endoscopy-first strategy requiring laparoscopic assistance. The primary endpoint was conversion to OC. Secondary endpoints included pathologic malignancy and ≥ T2 disease. Clinically relevant preoperative and intraoperative variables were analyzed using Firth penalized logistic regression. Internal validation was performed using bootstrap resampling. A 10-point CELS-OC score was derived and integrated into a stepwise operative algorithm. RESULTS: Seventy patients were included, of whom 25 (35.7%) required conversion to OC. Final pathology revealed malignancy in 20 patients (28.6%). Ulceration or depression (aOR 19.15, 95% CI 3.45-106.36; p < 0.001), lesion size ≥ 40 mm (aOR 6.40, 95% CI 1.35-30.33; p = 0.019), and the non-lifting sign (aOR 5.36, 95% CI 1.05-27.44; p = 0.044) were independently associated with conversion. Ulceration or depression remained predictive of malignancy (aOR 13.07, 95% CI 3.10-55.04; p = 0.001). The score demonstrated strong discrimination for OC conversion (AUC 0.928) and malignancy (AUC 0.874). High-risk lesions (≥ 7 points) had OC conversion and malignancy rates of 93.8% and 75.0%, respectively. CONCLUSIONS: In complex colonic polyps with benign biopsy findings, specific morphologic and intraoperative features are associated with conversion to OC and malignant pathology. The CELS-OC score integrates these predictors into a structured intraoperative framework that may improve organ-preserving selection while maintaining oncologic safety. External validation is needed.
引用
- Oruc M, Aktas O, Erkaya M, et al. A structured conversion score to guide oncologic colectomy during combined endoscopic-laparoscopic surgery for complex colonic polyps. Surg Endosc. 2026. PMID: 42557487. doi:10.1007/s00464-026-13210-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。